Altimmune Inc [ALT] Revenue clocked in at $0.28 million, up 0.62% YTD: What’s Next?
Altimmune Inc [NASDAQ: ALT] gained 23.04% or 2.12 points to close at $11.32 with a heavy trading volume of 17605276 shares. The company report on January 2, 2024 at 7:30 AM that Altimmune Announces Presentation of Pemvidutide Clinical Data at Upcoming NASH-TAG Conference on January